What is it about?
Spironolactone has been around for 60 years. In terms of the roles of Mineralocorticoid Receptor Antagonists (MRAs) , we have just scratched the surface: watch this space.
Featured Image
Why is it important?
Because there is increasing evidence, for example, that hyperaldosteronism may play a significant role in over 50% of hypertension, for example.
Perspectives
It's exciting times, but there is an element of attempting to turn around the Queen Mary.
John Funder
Hudson Institute
Read the Original
This page is a summary of: Spironolactone in cardiovascular disease: an expanding universe?, F1000Research, September 2017, Faculty of 1000, Ltd.,
DOI: 10.12688/f1000research.11887.1.
You can read the full text:
Contributors
The following have contributed to this page
